A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...
For 25 years, researchers have engineered immune cells to hunt down HIV. The approach, known as chimeric antigen receptor (CAR) T-cell therapy, extracts a patient’s T cells, engineers them to ...
In a new Science Advances paper, a research team led by scientists at Albert Einstein College of Medicine describe a manufacturing strategy for engineering immune cells that dramatically prolongs ...
March 13, 2026—(BRONX, NY)—A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness ...
The co-infection of HIV and Mycobacterium tuberculosis represents a major global health challenge, with each pathogen exacerbating the progression of the other. HIV undermines host defence by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results